Bank of New York Mellon’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bank of New York Mellon’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-22,261	Closed	-$89K	–	4509
2022 Q3	$89K	Buy	22,261 +1,596	+8%	+$12.1K	﹤0.01%	4218
2022 Q2	$234K	Sell	20,665 -30,365	-60%	-$364K	﹤0.01%	3999
2022 Q1	$829K	Sell	51,030 -18,316	-26%	-$469K	﹤0.01%	3422
2021 Q4	$3.29M	Buy	69,346 +41,056	+145%	+$2.46M	﹤0.01%	2691
2021 Q3	$2.05M	Hold	28,290	–	–	﹤0.01%	2959
2021 Q2	$2.38M	Buy	+28,290	New	+$1.87M	﹤0.01%	2883

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Cederberg Capital London, United Kingdom $186M AUM 21.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of New York Mellon's NBP Position: Q4 2022 in Review

Bank of New York Mellon sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2022, closing a stake of 22,261 shares — an estimated $89K sold.

Bank of New York Mellon first reported a position in NBP in Q2 2021 and held it in 6 quarters. The position peaked at $3.29M in Q4 2021. 69 funds tracked by Wall St. Rank hold NBP as of Q4 2022.

Bank of New York Mellon reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2022 after selling out during the quarter.
Bank of New York Mellon sold 22,261 NovaBridge Biosciences American Depositary Shares shares in Q4 2022, an estimated $89K.
Bank of New York Mellon first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 6 quarters.
Bank of New York Mellon's NovaBridge Biosciences American Depositary Shares position peaked at $3.29M in Q4 2021.
69 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2022.

Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.